CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31

Cannabis Bioscience International Holdings, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026

$0.00+0.00 (+33.33%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Cannabis Bioscience International has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements Cannabis Bioscience International filed with the SEC

Aug 21, 2024, 7:19 PM ET
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Material agreement · Executive or director change · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Dec 14, 2023, 2:06 PM ET
This Subscription Agreement (the “ Subscription
Other events · EX-99.1 to Form 8-K

Parsed from the XBRL in Cannabis Bioscience International's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 28, 2009
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CBIH.

Revenue growth-64.1% · median -62.3%

Gross margin78.8% · median -83.4%

Operating margin-322.6% · median -2020.0%

Net margin-416.8% · median -2449.0%

Advertisement
300 × 250